Paliperidone-d4 is a deuterium-labeled form of the active pharmaceutical ingredient paliperidone, an atypical antipsychotic compound used in pharmaceutical manufacturing and research. It is commonly employed as an internal standard in analytical studies due to its stable isotope labeling.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1020719-55-4
4-amino-2,3,5,6-tetradeuterio-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
pharmaceutical raw material
Ancitabine hydrochloride
pharmaceutical raw material
Pyra
pharmaceutical raw material
(R)-tert-Butyl 3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate
pharmaceutical raw material
Paliperidone
pharmaceutical raw material
Risperidone
pharmaceutical raw material
Risperidone hydrochloride
pharmaceutical raw material
Paliperidone palmitate
pharmaceutical raw material
9-hydroxy-2-methyl-3-[1,1,2,2-tetradeuterio-2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
PMXMIIMHBWHSKN-FJVJJXCISA-N
[2H]C([2H])(C1=C(N=C2C(CCCN2C1=O)O)C)C([2H])([2H])N3CCC(CC3)C4=NOC5=C4C=CC(=C5)F